Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2393474
Max Phase: Preclinical
Molecular Formula: C27H22N4O5S
Molecular Weight: 514.56
Molecule Type: Small molecule
Associated Items:
ID: ALA2393474
Max Phase: Preclinical
Molecular Formula: C27H22N4O5S
Molecular Weight: 514.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)/C(CC(=O)c1cccc2c1C(=O)c1ccccc1C2=O)=N\NC(=S)NCc1cccnc1
Standard InChI: InChI=1S/C27H22N4O5S/c1-2-36-26(35)21(30-31-27(37)29-15-16-7-6-12-28-14-16)13-22(32)19-10-5-11-20-23(19)25(34)18-9-4-3-8-17(18)24(20)33/h3-12,14H,2,13,15H2,1H3,(H2,29,31,37)/b30-21-
Standard InChI Key: UWYAUHDZMZYQJL-OFWBYEQRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 514.56 | Molecular Weight (Monoisotopic): 514.1311 | AlogP: 3.01 | #Rotatable Bonds: 8 |
Polar Surface Area: 126.82 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.17 | CX Basic pKa: 4.82 | CX LogP: 4.10 | CX LogD: 4.10 |
Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.12 | Np Likeness Score: -0.68 |
1. Marković V, Janićijević A, Stanojković T, Kolundžija B, Sladić D, Vujčić M, Janović B, Joksović L, Djurdjević PT, Todorović N, Trifunović S, Joksović MD.. (2013) Synthesis, cytotoxic activity and DNA-interaction studies of novel anthraquinone-thiosemicarbazones with tautomerizable methylene group., 64 [PMID:23644206] [10.1016/j.ejmech.2013.03.071] |
Source(1):